Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee hears wide‑ranging testimony on kratom regulation; health department opposes current draft
Summary
The Human Services Committee heard extensive testimony on HB1566, a bill to regulate kratom, with industry groups asking for a Kratom Consumer Protection Act approach and the Department of Health urging revisions and caution about FDA standards.
The House Human Services Committee on Tuesday heard extensive testimony for and against House Bill 1566, a proposed regulatory framework for kratom products. Witnesses representing industry, consumer coalitions and the American Kratom Association urged regulation rather than prohibition; the Department of Health and Human Services opposed the bill as currently drafted and urged significant changes.
Sponsor Representative Dan Johnston said HB1566 was drafted after committee members concluded an outright scheduling ban was not the right approach. "One of the things we learned ... is that there's no regulatory framework in place. And so that's the impetus for 1566," Johnston…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
